Seller record · Telehealth service

OriaMeds

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the product pages, the about page or the policies.

At a glance

OriaMedsTelehealth service

7/8criteria passed

Price: Semaglutide $89 for an introductory first month, then $199 a month; tirzepatide $129, then $369
Sells: compounded semaglutide, compounded tirzepatide
FDA letters: None on file

Visit OriaMeds See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform selling compounded semaglutide and tirzepatide at one price for every dose, with a discounted first month, through an outside provider network. Care starts with a free medical intake, and every page names its partner pharmacy with a street address.

Operating entity No legal entity name appears in the footer, in the terms and conditions, in the privacy policy or in the refund and cancellation policy, which name the business only as OriaMeds.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	OriaMeds' about page; OriaMeds' GLP-1 semaglutide page
S2	Prescription gating	PASS	OriaMeds' GLP-1 semaglutide page; OriaMeds' GLP-1 tirzepatide page; OriaMeds' website
S3	Pharmacy identification	PASS	OriaMeds' website; OriaMeds' about page
S4	Compounding disclosure	PASS	OriaMeds' GLP-1 semaglutide page; OriaMeds' website; OriaMeds' terms
S5	Analytical documentation	FAIL	OriaMeds' GLP-1 semaglutide page; OriaMeds' about page; OriaMeds' terms
S6	Business address	PASS	OriaMeds' website; OriaMeds' terms; OriaMeds' privacy policy
S7	Price disclosure	PASS	OriaMeds' GLP-1 semaglutide page; OriaMeds' GLP-1 tirzepatide page; OriaMeds' website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSIndependent licensed providers of the WizDoc provider network review each intake and medical history and issue a prescription only if treatment is appropriate, with a video consultation where the state requires one.Source: OriaMeds' about page; OriaMeds' GLP-1 semaglutide page.

S2PASSThe start buttons point to a free medical intake, and the product pages say the buyer is charged only after a licensed provider reviews the intake and issues a prescription, and is not charged if not eligible.Source: OriaMeds' GLP-1 semaglutide page; OriaMeds' GLP-1 tirzepatide page; OriaMeds' website.

S3PASSThe footer of every page names the partner pharmacy as PerfectRx at 5810 Long Prairie Rd, Flower Mound, TX 75028, and the about page names it as the pharmacy partner.Source: OriaMeds' website; OriaMeds' about page.

S4PASSThe product pages, the answers on the home page and the terms state that compounded medications are not FDA-approved and that the FDA does not verify their safety, effectiveness or quality.Source: OriaMeds' GLP-1 semaglutide page; OriaMeds' website; OriaMeds' terms.

S5FAILNo certificate of analysis or lot document is published on the product pages, the about page or the policies.Source: OriaMeds' GLP-1 semaglutide page; OriaMeds' about page; OriaMeds' terms.

S6PASS30 N Gould St, Ste R, Sheridan, WY 82801, printed under the name OriaMeds in the footer of every page and of each policy page.Source: OriaMeds' website; OriaMeds' terms; OriaMeds' privacy policy.

S7PASSCompounded semaglutide at $89 for an introductory first month, then $199 a month, or $209 a month on the 3-month and 6-month plans. Compounded tirzepatide at $129 for an introductory first month, then $369 a month, or $316 a month on the 3-month plan and $299 a month on the 6-month plan. The price includes the provider review, medication and shipping and does not change with the dose.Source: OriaMeds' GLP-1 semaglutide page; OriaMeds' GLP-1 tirzepatide page; OriaMeds' website.

S8PASSNo FDA warning letter names OriaMeds or Oria, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit OriaMeds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.